12 Health Care Stocks Moving In Friday's After-Market Session

12 Health Care Stocks Moving In Friday's After-Market Session

Gainers

  • CASI Pharmaceuticals CASI shares moved upwards by 19.02% to $1.11 during Friday's after-market session. Trading volume for this security closed at 2.5 million, accounting for 100.67% of its average full-day volume over the last 100 days. The company's market cap stands at $155.1 million.
  • Compass Therapeutics CMPX shares moved upwards by 9.77% to $3.82. The market value of their outstanding shares is at $374.4 million.
  • Clene CLNN shares rose 6.93% to $5.4. The market value of their outstanding shares is at $335.8 million.
  • Redhill Biopharma RDHL shares moved upwards by 5.65% to $2.99. The market value of their outstanding shares is at $139.6 million.
  • Galera Therapeutics GRTX shares rose 4.51% to $1.62. The market value of their outstanding shares is at $42.8 million.
  • Stealth BioTherapeutics MITO shares moved upwards by 4.24% to $0.98. The market value of their outstanding shares is at $56.4 million.

Losers

  • Unity Biotechnology UBX shares decreased by 3.85% to $2.5 during Friday's after-market session. The market value of their outstanding shares is at $144.3 million.
  • Bio-Path Holdings BPTH shares declined by 3.45% to $4.2. The market value of their outstanding shares is at $30.0 million.
  • Biophytis BPTS shares decreased by 3.32% to $4.96. The market value of their outstanding shares is at $62.3 million.
  • Zosano Pharma ZSAN shares declined by 2.12% to $0.62. The market value of their outstanding shares is at $73.3 million.
  • Kala Pharmaceuticals KALA shares declined by 2.1% to $1.87. The market value of their outstanding shares is at $122.4 million. As per the news, the Q3 earnings report came out 4 days ago.
  • Athersys ATHX shares decreased by 1.99% to $0.99. The market value of their outstanding shares is at $231.7 million. As per the news, the Q3 earnings report came out 4 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-TFMMovers